08/12/2024
3:31 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
7:00 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
5:00 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
06/20/2024
4:56 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:35 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:44 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:00 PM | Aerovate Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/07/2024
7:29 PM | Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:10 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:57 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:39 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:59 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
3:16 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024
4:23 PM | Aerovate Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:18 AM | Aerovate Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:19 AM | Aerovate Therapeutics (Filer)
| Form DEFA14A | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:25 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:42 PM | Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad) Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs).
If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. |
04/01/2024
6:18 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
6:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:31 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
8:22 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:15 PM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:12 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:35 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:37 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
2:28 PM | Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:34 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
6:09 PM | Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
| Form SC 13D/A | |
02/20/2024
5:38 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
3:28 PM | Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:45 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:29 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:11 PM | Aerovate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
6:59 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:50 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:24 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why You Should NOT Trade This Market (Ad) You'll be interested in our 5-Day Options Trading Challenge, starting September 23.
So, what makes this different from every other options research you may have seen?
Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars... Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go |
12/05/2023
7:04 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:13 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
3:46 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:16 AM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:03 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
